scholarly journals Functional Capacity, Cognition And Spatial Navigation In Older Adults With Mild Cognitive Impairment

2019 ◽  
Vol 51 (Supplement) ◽  
pp. 108
Author(s):  
Jessica Plácido ◽  
José Vinicius Ferreira ◽  
Felipe Oliveira ◽  
Paula Santana ◽  
Renato Sobral Monteiro-Junior ◽  
...  
Nutrients ◽  
2020 ◽  
Vol 12 (2) ◽  
pp. 325 ◽  
Author(s):  
Pinelopi S. Stavrinou ◽  
Eleni Andreou ◽  
George Aphamis ◽  
Marios Pantzaris ◽  
Melina Ioannou ◽  
...  

The aim of the present study was to examine the effects of a high-dose omega-3 and omega-6 fatty acids supplementation, in combination with antioxidant vitamins, on cognitive function and functional capacity of older adults with mild cognitive impairment (MCI), over a 6-month period in a randomized, double-blind, placebo-controlled trial. Forty-six older adults with MCI (age: 78.8 ± 7.3 years) were randomized 1:1 to receive either a 20 mL dose of a formula containing a mixture of omega-3 (810 mg Eicosapentaenoic acid and 4140 mg Docosahexaenoic acid) and omega-6 fatty acids (1800 mg gamma-Linolenic acid and 3150 mg Linoleic acid) (1:1 w/w), with 0.6 mg vitamin A, vitamin E (22 mg) plus pure γ-tocopherol (760 mg), or 20 mL placebo containing olive oil. Participants completed assessments of cognitive function, functional capacity, body composition and various aspects of quality of life at baseline and following three and six months of supplementation. Thirty-six participants completed the study (eighteen from each group). A significant interaction between supplementation and time was found on cognitive function (Addenbrooke’s Cognitive Examination -Revised (ACE-R), Mini-Mental State Examination (MMSE) and Stroop Color and Word Test (STROOP) color test; p < 0.001, p = 0.011 and p = 0.037, respectively), functional capacity (6-min walk test and sit-to-stand-60; p = 0.028 and p = 0.032, respectively), fatigue (p < 0.001), physical health (p = 0.007), and daily sleepiness (p = 0.007)—showing a favorable improvement for the participants receiving the supplement. The results indicate that this nutritional modality could be promising for reducing cognitive and functional decline in the elderly with MCI.


2021 ◽  
Vol 2 (Supplement_1) ◽  
pp. A37-A37
Author(s):  
C Haroutonian ◽  
I Johnston ◽  
A Ricciardiello ◽  
A Lam ◽  
R Grunstein ◽  
...  

Abstract Introduction The ability to navigate oneself in space is one of the first functional impairments in Alzheimer’s disease (AD). A 3D-computerised spatial navigation (SN) task was designed to delineate, for the first time in a sleep-dependent memory paradigm, egocentric and allocentric SN, the latter identified as one cognitive biomarker of AD. We examined group differences in SN memory and associations with sleep macroarchitecture. Methods Older adults with mild cognitive impairment (MCI, n=32) and controls (n=25) underwent overnight polysomnography and completed the SN task before and after sleep. Participants learnt the location of a target over 5 trials (familiar location; egocentric-dependent), then were instructed to find the target from a novel start location (allocentric-dependent). Memory % retention (MR) from both start locations were calculated by the XY coordinate of marked location to correct location of the target, pre- and post-sleep. Navigational strategies were coded using self-reported description of how participants’ found the target. Associations between MR with REM and SWS % duration, and AHI in REM and NREM were examined using Spearman’s correlations. Results Repeated-measures ANOVA showed Controls MR improved overnight whereas MCI performed worse (F=7.46, p=.009), with greatest differences on familiar start location MR (p=.02). Strategy as a covariate revealed a location by strategy interaction (p=01). Novel location MR was associated with REM%, rho=.448, (p=.02) in Controls, and REM-AHI, rho=.400 (p=.02) in MCI. Conclusion Behavioural and self-reported results suggest disrupted SN strategies relative to environment in MCI. Future studies should examine SN in association with sleep-wake neurophysiology and neuronal integrity.


2021 ◽  
pp. 1-10
Author(s):  
Jessica Plácido ◽  
José Vinicius Ferreira ◽  
Juliana Araújo ◽  
Felipe de Oliveira Silva ◽  
Renan Baltar Ferreira ◽  
...  

Background: Spatial navigation and dual-task (DT) performance may represent a low-cost approach to the identification of the cognitive decline in older adults and may support the clinical diagnosis of mild cognitive impairment (MCI) and Alzheimer’s disease (AD). Objective: To assess the accuracy of different types of motor tasks in differentiating older persons with MCI and AD from healthy peers. Methods: Older adults aged 60 years or over (n = 105; healthy = 39; MCI = 23; AD = 43) were evaluated by the floor maze test (FMT), the senior fitness test, and DT performance. Receiver operating characteristic curve (ROC) analysis was used to evaluate the accuracy of the tests. We also performed principal component analysis (PCA) and logistic regression analysis to explore the variance and possible associations of the variables within the sample. Results: FMT (AUC = 0.84, sensitivity = 75.7%, specificity = 76.1%, p <  0.001) and DT (AUC = 0.87, sensitivity = 80.4%, specificity = 86.9%, p <  0.001) showed the highest performance for distinguishing MCI from AD individuals. Moreover, FMT presented better sensitivity in distinguishing AD patients from their healthy peers (AUC = 0.93, sensitivity = 94%, specificity = 85.6%, p <  0.001) when compared to the Mini-Mental State Examination. PCA revealed that the motor test performance explains a total of 73.9% of the variance of the sample. Additionally, the results of the motor tests were not influenced by age and education. Conclusion: Spatial navigation tests showed better accuracy than usual cognitive screening tests in distinguishing patients with neurocognitive disorders.


2017 ◽  
Vol 2 (2) ◽  
pp. 110-116
Author(s):  
Valarie B. Fleming ◽  
Joyce L. Harris

Across the breadth of acquired neurogenic communication disorders, mild cognitive impairment (MCI) may go undetected, underreported, and untreated. In addition to stigma and distrust of healthcare systems, other barriers contribute to decreased identification, healthcare access, and service utilization for Hispanic and African American adults with MCI. Speech-language pathologists (SLPs) have significant roles in prevention, education, management, and support of older adults, the population must susceptible to MCI.


2018 ◽  
Vol 15 (3) ◽  
pp. 219-228 ◽  
Author(s):  
Jiri Cerman ◽  
Ross Andel ◽  
Jan Laczo ◽  
Martin Vyhnalek ◽  
Zuzana Nedelska ◽  
...  

Background: Great effort has been put into developing simple and feasible tools capable to detect Alzheimer's disease (AD) in its early clinical stage. Spatial navigation impairment occurs very early in AD and is detectable even in the stage of mild cognitive impairment (MCI). Objective: The aim was to describe the frequency of self-reported spatial navigation complaints in patients with subjective cognitive decline (SCD), amnestic and non-amnestic MCI (aMCI, naMCI) and AD dementia and to assess whether a simple questionnaire based on these complaints may be used to detect early AD. Method: In total 184 subjects: patients with aMCI (n=61), naMCI (n=27), SCD (n=63), dementia due to AD (n=20) and normal controls (n=13) were recruited. The subjects underwent neuropsychological examination and were administered a questionnaire addressing spatial navigation complaints. Responses to the 15 items questionnaire were scaled into four categories (no, minor, moderate and major complaints). Results: 55% of patients with aMCI, 64% with naMCI, 68% with SCD and 72% with AD complained about their spatial navigation. 38-61% of these complaints were moderate or major. Only 33% normal controls expressed complaints and none was ranked as moderate or major. The SCD, aMCI and AD dementia patients were more likely to express complaints than normal controls (p's<0.050) after adjusting for age, education, sex, depressive symptoms (OR for SCD=4.00, aMCI=3.90, AD dementia=7.02) or anxiety (OR for SCD=3.59, aMCI=3.64, AD dementia=6.41). Conclusion: Spatial navigation complaints are a frequent symptom not only in AD, but also in SCD and aMCI and can potentially be detected by a simple and inexpensive questionnaire.


Sign in / Sign up

Export Citation Format

Share Document